ELN, LIMS and other legacy software have played an important role in many research projects, but their limitations hamper data visibility and obstruct collaboration, which hinders further innovations and progress. Does your LIMS: Prevent the use of material not on…
The global pandemic is shining a spotlight on the power of biologics, both vaccines and antibody therapeutics, to prevent serious infections and treat disease.
Info Sheet Why? Because studies can’t be replicated. If a study in science can’t be replicated, is it still viable? Scientific studies are notoriously difficult to reproduce. A study by Plos Biology showed that about $28 billion every year is…
Discover how digital transformation can be so much more than just insights About this roundtable The pace of innovation in pharma is accelerating and significant investment needs to be made for the laboratory to keep up. Labs need to…
The Biopharmaceutical industry has big ambitions to accelerate the move towards industry 4.0. In this whitepaper we explore some of the major bottlenecks in the development lifecycle, the current barriers to effective digital transformation and explore the role an effective…
How can out-of-the box workflows in IDBS Polar, the world’s first BioPharma Lifecycle Management system, enable six times faster time to value and help you tackle the biggest challenges in process design, optimization, scale-up and technology transfer? Key points: Biopharma…
The licensing and integration of Scitara DLX technology will offer IDBS users plug-and-play connectivity to any instrument or application in regulated and non-regulated laboratories
